Isolated lung perfusion with doxorubicin reduces cardiac and host toxicities associated with systemic administration

Annals of Thoracic Surgery

Volumn 61, Issue 3, 1996, Pages 969-972

  Ng, Bruce ^a   Hochwald, Steven N ^a   Burt, Michael E ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CARDIOTOXICITY; HEART INDEX; HEART OUTPUT; INTRAVENOUS DRUG ADMINISTRATION; LUNG METASTASIS; LUNG PERFUSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030003736     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/0003-4975(95)01183-8     Document Type: Article

References (14)

1. Potter DA, Glenn J, Kinsella T. Patterns of recurrence in patients with high grade soft-tissue sarcomas. J Clin Oncol 1958;3:353-66.
2. Casson AG, Putnam JB, Natarajan G, et al. Five-year survival after pulmonary metastasectomy for adult soft tissue sarcoma. Cancer 1992;69:662-8.
3. Lanza LA, Putnam JB, Benjamin RS, Roth JA. Response to chemotherapy does not predict survival after resection of sarcomatous pulmonary metastases. Ann Thorac Surg 1991; 51:219-24.
4. Gottlieb JA, Baker LH, O'Bryan RM, et al. Adriamycin (NSC-123127) used alone and in combination for soft tissue and bony sarcoma. Cancer Chemother Rep 1975;6:271-82.
5. Casper ES, Gaynor JJ, Hajdu SI, et al. A prospective randomized trial of adjuvant chemotherapy with bolus versus con-tinuous infusion of doxorubicin in patients with high-grade extremity soft tissue sarcoma and an analysis of prognostic factors. Cancer 1991;68:1221-9.
6. Weksler B, Ng B, Lenert JT, Burt ME. Isolated single-lung perfusion with doxorubicin is pharmacokinetically superior to intravenous injection. Ann Thorac Surg 1993;56:209-14.
7. Weksler B, Lenert J, Ng B, Burt M. Isolated single lung perfusion with doxorubicin is effective in eradicating soft tissue sarcoma lung métastases in a rat model. J Thorac Cardiovasc Surg 1994;107:50-4.
8. Tuma RF, Vasthare US, Irion GL, Wiedeman MP. Considerations in use of microspheres for flow measurements in anesthetized rat. Am J Physiol 1986;250:H137-43.
9. Wheeler RH, Ensminger WD, Thrall JH, Anderson JL. High-dose doxorubicin: an exploration of the dose-response curve in human neoplasia. Cancer Treat Rep 1982;66:493-8.
10. Johnston MR, Minchin RF, Shull JH, et al. Isolated lung perfusion with Adriamycin: a preclinical study. Cancer 1983; 52:404-9.
11. Johnston MR, Christensen CW, Minchin RF, et al. Isolated total lung perfusion as a means to deliver organ-specific chemotherapy: long-term studies in animals. Surgery 1985; 98:35-44.
12. Baciewicz FA, Arredondo M, Chaudhuri B, et al. Pharmacokinetics and toxicity of isolated perfusion of lung with doxorubicin. J Surg Res 1991;50:124-8.
13. Ng B, Lenert JT, Weksler B, Port JL, Ellis JL, Burt M. Isolated lung perfusion with FUDR is an effective treatment for colorectal adenocarcinoma lung metastases in rats. Ann Thorac Surg 1995;59:205-8.
14. Port JL, Hochwald SN, Wang H-Y, Burt ME. Buthionine sulfoximine pretreatment potentiates the effect of isolated lung perfusion with doxorubicin. Ann Thorac Surg 1995;60: 239-44.